Simultaneous measurement of circulating intercellular adhesion molecule-1 and serum copper zinc superoxide dismutase activity in patients with malignant melanoma.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Oncology Report

• Publication date

  1998-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/OR.5.2.473PMID 9468582
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intercellular adhesion molecule-1

  2020cited by this paper
• Effects of cytokine‐mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells

  2006cited by this paper
• Characterization of non pigmented B16 melanoma cell-derived cytotoxic factors.

  1997cited by this paper
• Running exercise may reduce risk for lung and liver cancer by inducing activity of antioxidant and phase II enzymes.

  1997cited by this paper
• Simultaneous measurement of serum 5-S-cysteinyldopa, circulating intercellular adhesion molecule-1 and soluble interleukin-2 receptor levels in Japanese patients with malignant melanoma

  1997cited by this paper
• Differential patterns of HOX gene expression are associated with specific integrin and ICAM profiles in clonal populations isolated from a single human melanoma metastasis

  1996cited by this paper
• Imbalance in the antioxidant pool in melanoma cells and normal melanocytes from patients with melanoma.

  1996cited by this paper
• Increase in shedding of intercellular adhesion molecule-1 in human malignant melanoma cell lines treated with hyperthermia in vitro.

  1996cited by this paper
• Tumour necrosis factor (TNF) soluble receptors in malignant melanoma: correlation with soluble ICAM-1 levels.

  1996cited by this paper
• Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage.

  1996cited by this paper
• Soluble Intercellular Adhesion Molecule-1 and Serum Cytokines in Melanoma Patients Treated with Liposomes Containing Muramyl Tripeptide

  1995cited by this paper
• Serum levels of soluble cell adhesion molecules (ICAM-1, VCAM-1, E-selectin) and of cytokine TNF-alpha increase during interleukin-2 therapy.

  1995cited by this paper
• Human interleukin for DA cells/leukemia inhibitory factor and oncostatin M enhance membrane expression of intercellular adhesion molecule-1 on melanoma cells but not the shedding of its soluble form.

  1995cited by this paper
• Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides.

  1994cited by this paper
• [Position and recommendations of the Malignant Melanoma Committee of the German Society of Dermatology on diagnosis, treatment and after-care of malignant melanoma of the skin. Status 1993/94].

  1994cited by this paper
• Age-dependent basal level and induction capacity of copper-zinc and manganese superoxide dismutase and other scavenging enzyme activities in leukocytes from young and elderly adults.

  1993cited by this paper
• Differential expression and release of LFA‐3 and ICAM‐1 in human melanoma cell lines

  1993cited by this paper
• Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction.

  1993cited by this paper
• Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells.

  1993cited by this paper
• Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma.

  1993cited by this paper
• Soluble intercellular adhesion molecule 1 is released by human melanoma cells and is associated with tumor growth in nude mice.

  1992cited by this paper
• Copper,zinc superoxide dismutase is primarily a cytosolic protein in human cells.

  1992cited by this paper
• Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity.

  1991cited by this paper
• Lowered superoxide dismutase in highly metastatic B16 melanoma cells.

  1991cited by this paper
• Differential regulation of antioxidant enzymes in response to oxidants.

  1991cited by this paper
• Immunochemical quantification of Cu/Zn superoxide dismutase in prenatal diagnosis of Down's syndrome

  1990cited by this paper
• An immunohistochemical study of copper, zinc‐containing superoxide dismutase detected by a monoclonal antibody in gastric mucosa and gastric cancer

  1990cited by this paper
• Human serum immuno-reactive copper, zinc-superoxide dismutase assayed with an enzyme monoclonal immunosorbent in patients with digestive cancer.

  1989cited by this paper

• Serum matrix metalloproteinase-2 in patients with malignant melanoma

  2001cites this paper
• Serologische Tumormarker beim malignen Melanom

  2001cites this paper
• Serum protein S100β in patients with malignant melanoma detected by an immunoluminometric assay

  2000cites this paper
• Soluble ICAM‐1 seems to be related to prognosis in malignant melanoma

  1999cites this paper